Page last updated: 2024-10-22

acetazolamide and Adrenal Cancer

acetazolamide has been researched along with Adrenal Cancer in 2 studies

Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
KOBAYASHI, I1
Kondo, T1
Taniguchi, N1
Hirano, T1
Kawakami, Y1

Other Studies

2 other studies available for acetazolamide and Adrenal Cancer

ArticleYear
[STUDIES ON NEPHROPATHY OF POTASSIUM DEPLETION, WITH SPECIAL REFERENCE TO ACID-BASE BALANCE].
    Tohoku igaku zasshi, 1962, Volume: 66

    Topics: Acetazolamide; Acid-Base Equilibrium; Adrenal Gland Neoplasms; Ammonium Chloride; Animals; Desoxycor

1962
A novel low-activity form of carbonic anhydrase I in erythrocytes of patients with primary aldosteronism. Evidence for the presence of a mixed disulfide with glutathione.
    The Journal of biological chemistry, 1984, Dec-25, Volume: 259, Issue:24

    Topics: Acetazolamide; Adenoma; Adrenal Gland Neoplasms; Adult; Carbonic Anhydrases; Erythrocytes; Female; G

1984